Cirrhosis, Liver
Conditions
Brief summary
Liver transplantation is an effective treatment for end-stage liver disease. Cardiovascular complications are the common causes of death in liver transplant recipients. The presence of cirrhosis cardiomyopathy has a potential impact on the prognosis of liver transplant recipients. Therefore, it is important to identify the high risk factors with cirrhotic cardiomyopathy before transplantation, so as to intervene earlier and improve the prognosis of patients.
Interventions
None listed
Sponsors
The Affiliated Hospital of Qingdao University
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Diagnostic criteria for decompensated liver cirrhosis: according to the guidelines for diagnosis and treatment of liver cirrhosis in 2019; 2. Diagnostic criteria for cirrhotic cardiomyopathy: in accordance with the revised criteria of CCM of international multidisciplinary Alliance for cirrhotic cardiomyopathy in 2019, the preoperative echocardiographic images of all patients were reviewed, and the systolic and diastolic dysfunction of all patients were evaluated.
Exclusion criteria
1. the compensatory liver cirrhosis, primary liver cancer without liver cirrhosis 2. Multiple organ transplantation or multiple organ transplantation 3. The preoperative echocardiographic data were not fully recorded, so that the exact diagnosis could not be made 4. There was no follow-up data or baseline data
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| perioperative cardiovascular events | 2012.1.1-2022.8 | there are differences between 2 groups. |
Contacts
Primary Contactshenghua Bi
Backup Contactxue Jing
Outcome results
None listed